European Medicines Agency also said the vaccine’s benefits still far outweigh its risks
CDC Panel Says It Needs More Time to Study J&J Vaccine Clotting Cases
Advisers to the CDC say they do not have enough information or time to recommend how to proceed and they will meet again within 10 days
Rare Thrombosis, Thrombocytopenia Seen After AstraZeneca COVID-19 Vaccine
Reports document 16 reactions in young European patients following first dose of ChAdOx1 nCoV-19 vaccine
FDA, CDC Call for Pause in J&J COVID-19 Vaccine After Six People Develop Clots
The six cases involved a cerebral venous sinus thrombosis and occurred in women between the ages of 18 and 48 years
Blood Clot Risk High Following COVID-19 Hospitalization
However, anticoagulation cuts risk for major thromboembolic events by 46 percent
‘Possible Link’ Found Between AstraZeneca COVID-19 Vaccine, Rare Blood Clots
EU agency experts reviewed several dozen cases and determined that such clots are ‘very rare’ side effects of the vaccine
No Increase Seen in Outpatient VTE for SARS-CoV-2-Positive Patients
Patients with positive SARS-CoV-2 test had higher 30-day incidence of hospital-associated, but not outpatient, VTE
More Cases of Blood Clots Linked to AstraZeneca COVID-19 Vaccine
Britain’s medical regulatory agency has received 30 reports of clotting events after people were vaccinated
AstraZeneca Says Its COVID-19 Vaccine Is Safe, Despite Reports of Deadly Clots
The AstraZeneca vaccine, developed with researchers from Oxford University, has been heavily used in Britain
Early Anticoagulation May Not Up Survival in Severe COVID-19
Venous thromboembolism seen in 6.3 percent and major bleeding seen in 2.8 percent of critically ill COVID-19 patients